|
Real-time Estimate
Tradegate
10:23:39 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 80.85 EUR | +2.21% |
|
+3.00% | +26.79% |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
| 08-10 | Orion partner's phase 3 study with levosimendan missed its goals | FW |
Chart: Technical Analysis
Stock exchange
Nasdaq Helsinki
ORNBV 80.70 €
+2.02%
2.62M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Helsinki
| ORNBV | 80.70EUR | +2.02% | 2.62M € | |
CBOE
| ORNBVh | 80.85EUR | +2.24% | 1.61M € | |
|
London S.E.
| 0M2O | 78.82EUR | -0.13% | 78.82 € | |
|
Tradegate
| OFK | 79.45EUR | +0.44% | 79.45 € | |
|
Deutsche Boerse AG
| OFK | 79.10EUR | +0.25% | 0 € | |
|
CBOE
| 0M2O | 78.80EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| OFK | 80.65EUR | +2.09% | 0 € | |
|
Boerse Muenchen
| OFK | 80.60EUR | +1.77% | 0 € | |
|
Berne S.E.
| OFK | 74.03CHF | +0.06% | 0 CHF | |
|
Borsa Italiana
| 1ORNBV | 76.35EUR | -3.11% | 0 € | |
Nasdaq Helsinki
| ORNAV | 80.60EUR | +2.03% | 455K € | |
|
CBOE
| ORNAVh | 80.40EUR | +2.03% | 108K € | |
|
CBOE
| 0M2N | 63.25EUR | 0.00% | 0 € | |
|
Deutsche Boerse AG
| OFKB | 78.00EUR | 0.00% | 0 € | |
Deutsche Boerse AG
| OFK0 | 39.40EUR | 0.00% | 0 € | |
|
OTC Markets
| ORINY | 43.02USD | +2.20% | 27.32K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 82.25 | 82.25 | 81.5 |
| Spread/Res. | -1.88% | -1.88% | -0.98% |
| Spread/Supp. | +7.31% | +11.85% | +19.82% |
| Support | 75.2 | 72.15 | 67.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORNBV Stock
- Charts Orion Oyj
Select your edition
All financial news and data tailored to specific country editions
